Tirzepatide Reduces Heart Failure Events in HFpEF With Obesity
SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart failure and a preserved ejection fraction and obesity.
Medscape Medical News
source https://www.medscape.com/viewarticle/tirzepatide-reduces-heart-failure-events-hfpef-obesity-2024a1000kx5?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/tirzepatide-reduces-heart-failure-events-hfpef-obesity-2024a1000kx5?src=rss
Comments
Post a Comment